Who owns Cytomx Therapeutics?
- Ticker: CTMX
- CUSIP Number: 23284f105
Tip: Access positions for across all investors
Analyze quarterly positions in Cytomx Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Cytomx Therapeutics stock
Who bought or sold Cytomx Therapeutics this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 6.6M | $10M | 0% | Dec 2023 |
|
Tang Capital Management | 6.6M | $10M | 2% | Dec 2023 |
|
Vanguard Group | 4.9M | $7.6M | 0% | Dec 2023 |
|
Laurion Capital Management | 1.1M | $1.7M | -8% | Dec 2023 |
|
Bronte Capital Management Pty | 920k | $1.4M | -1% | Dec 2023 |
|
Millennium Management | 794k | $1.2M | 14% | Dec 2023 |
|
Jacobs Levy Equity Management | 791k | $1.2M | -25% | Dec 2023 |
|
Assenagon Asset Management | 405k | $627k | -5% | Dec 2023 |
|
Marshall Wace | 363k | $563k | -4% | Dec 2023 |
|
BBK Capital Partners | 306k | $475k | -4% | Dec 2023 |
|
Toroso Investments | 306k | $475k | -4% | Dec 2023 |
|
Citadel Advisors | 276k | $428k | 181% | Dec 2023 |
|
Bank of New York Mellon | 267k | $414k | 0% | Dec 2023 |
|
Congress Park Capital | 234k | $510k | -2% | Mar 2024 |
|
Clearline Capital | 197k | $305k | 0% | Dec 2023 |
|
Connor, Clark & Lunn Investment Management | 197k | $305k | 35% | Dec 2023 |
|
Squarepoint Ops | 151k | $233k | -13% | Dec 2023 |
|
GSA Capital Partners | 104k | $161k | 100% | Dec 2023 |
|
CornerCap Investment Counsel | 81k | $126k | 0% | Dec 2023 |
|
Private Advisor | 73k | $113k | 0% | Dec 2023 |
|
Bank Of Montreal | 71k | $113k | 100% | Dec 2023 |
|
Commonwealth Equity Services | 53k | $83k | 0% | Dec 2023 |
|
Tudor Investment Corporation | 45k | $69k | 0% | Dec 2023 |
|
Russell Investments | 42k | $65k | -9% | Dec 2023 |
|
Two Sigma Advisers | 41k | $64k | -62% | Dec 2023 |
|
Jane Street | 29k | $45k | 100% | Dec 2023 |
|
Franklin Resources | 27k | $42k | 0% | Dec 2023 |
|
Charles Schwab Investment Management | 25k | $39k | 0% | Dec 2023 |
|
AlphaMark Advisors | 23k | $36k | 120% | Dec 2023 |
|
UBS Group | 20k | $31k | 7% | Dec 2023 |
|
Mackenzie Financial | 20k | $31k | 26% | Dec 2023 |
|
Bank of America Corporation | 18k | $28k | -30% | Dec 2023 |
|
Taddei, Ludwig & Associates | 17k | $27k | 0% | Dec 2023 |
|
Two Sigma Investments | 14k | $22k | -72% | Dec 2023 |
|
IPG Investment Advisors | 13k | $19k | 100% | Dec 2023 |
|
D. E. Shaw & Co | 12k | $18k | -84% | Dec 2023 |
|
Vontobel Holding | 10k | $16k | 0% | Dec 2023 |
|
Byrne Asset Management | 8.0k | $12k | 0% | Dec 2023 |
|
Whittier Trust | 6.6k | $10k | 0% | Dec 2023 |
|
Federated Investors | 3.5k | $5.4k | 146% | Dec 2023 |
|
Rhumbline Advisers | 1.3k | $2.0k | 0% | Dec 2023 |
|
Lazard Asset Management | 1.3k | $1.0k | 100% | Dec 2023 |
|
Cutler | 1.0k | $1.0k | 0% | Dec 2023 |
|
Royal Bank of Canada | 798.00 | $1.6k | 100% | Dec 2023 |
|
Wells Fargo & Company | 515.00 | $797.992500 | 6% | Dec 2023 |
|
Jpmorgan Chase & Co | 281.00 | $435.999600 | -84% | Dec 2023 |
|
Advisory Services Network | 274.00 | $425.001400 | 100% | Dec 2023 |
|
Raleigh Capital Management | 250.00 | $388.000000 | 0% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 78.00 | $121.001400 | -67% | Dec 2023 |
|